Spots Global Cancer Trial Database for An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Cancer of the Colon or Rectum That Has Spread
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Cancer of the Colon or Rectum That Has Spread
Official Title: A Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Metastatic Colorectal Cancers
Study ID: NCT03377361
Study Description
Brief Summary: The purpose of this study is to investigate treatment with nivolumab in combination with trametinib with or without ipilimumab in participants with previously treated cancer of the colon or rectum that has spread.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Local Institution - 0022, Birmingham, Alabama, United States
Local Institution - 0027, Los Angeles, California, United States
Local Institution - 0067, Los Angeles, California, United States
Local Institution - 0001, San Francisco, California, United States
Local Institution - 0107, Gainesville, Florida, United States
Local Institution - 0111, Miami, Florida, United States
Local Institution - 0028, Baltimore, Maryland, United States
Local Institution - 0116, Hattiesburg, Mississippi, United States
Local Institution - 0103, Saint Louis, Missouri, United States
Local Institution - 0104, New York, New York, United States
Local Institution - 0029, Charlotte, North Carolina, United States
Local Institution - 0100, Lancaster, Pennsylvania, United States
Local Institution - 0003, Philadelphia, Pennsylvania, United States
Thomas Jefferson University - Clinical Research Institute, Philadelphia, Pennsylvania, United States
Local Institution - 0101, Temple, Texas, United States
Local Institution - 0002, Madison, Wisconsin, United States
Local Institution - 0120, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Local Institution - 0122, Buenos Aires, Distrito Federal, Argentina
Local Institution - 0123, Ciudad Autónoma de Buenos Aires, Distrito Federal, Argentina
Local Institution - 0119, Buenos Aires, , Argentina
Local Institution - 0044, Blacktown, New South Wales, Australia
Local Institution - 0043, Southport, Queensland, Australia
Local Institution - 0068, Elizabeth Vale, South Australia, Australia
Local Institution - 0055, Clayton, Victoria, Australia
Local Institution - 0069, Heidelberg, Victoria, Australia
Local Institution, Woluwe-Saint-Lambert, , Belgium
Local Institution - 0113, Edmonton, Alberta, Canada
Local Institution - 0070, Toronto, Ontario, Canada
Local Institution - 0077, Montréal, Quebec, Canada
Local Institution - 0076, Ottawa, , Canada
Local Institution - 0117, Santiago, Metropolitana, Chile
Local Institution - 0118, Santiago, Región Metropolitana De Santiago, Chile
Local Institution - 0072, Olomouc, Olomoucký Kraj, Czechia
Local Institution - 0071, Brno, , Czechia
Local Institution - 0073, Hradec Kralove, , Czechia
Local Institution - 0004, Hannover, , Germany
Local Institution - 0095, Catania, , Italy
Local Institution - 0093, Milan, , Italy
Local Institution - 0092, Padova, , Italy
Local Institution - 0094, Rozzano, , Italy
Local Institution - 0079, Badalona, Barcelona [Barcelona], Spain
Local Institution - 0052, Barcelona, , Spain
Local Institution - 0114, Madrid, , Spain
Local Institution - 0051, Madrid, , Spain
Local Institution - 0115, Madrid, , Spain
Local Institution - 0080, Pamplona, , Spain
Local Institution - 0096, Sevilla, , Spain
Contact Details
Name: Bristol-Myers Squibb
Affiliation: Bristol-Myers Squibb
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
